Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 12;22(14):7457.
doi: 10.3390/ijms22147457.

Pharmacological Treatment for Social Cognition: Current Evidence

Cecilia Riccardi  1 , Cristiana Montemagni  1 , Elisa Del Favero  1 , Silvio Bellino  1 , Claudio Brasso  1 , Paola Rocca  1
Affiliations
Review

Pharmacological Treatment for Social Cognition: Current Evidence

Cecilia Riccardi et al. Int J Mol Sci. .

Abstract

Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it is still unclear whether they are effective on social cognition (SC) impairment. Furthermore, different medications are currently being studied to improve SC in patients with SZ. A literature search on this topic was conducted using the PubMed database. All kinds of publications (i.e., reviews, original contributions and case reports) written in English and published in the last 15 years were included. The aim of our literature review is to draw a picture of the current state of the pharmacological treatment of SC impairment in SZ.

Keywords: antipsychotic; pharmacological treatment; schizophrenia; social cognition.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the search and selection of the literature reports.
See this image and copyright information in PMC

References

    1. Bleuler E. Dementia praecox, oder Gruppe der Schizophrenien. Deuticke; Leipzig, Germany: 1911.
    1. Jaspers K. Allgemeine Psychopathologie. Springer; Berlin, Germany: 1913.
    1. Kraepelin E. Psychiatrie: Ein Lehrbuch fur Studierende und Arzte. 8th ed. Barth; Leipzig, Germany: 1913.
    1. Reichenberg A., Weiser M., Caspi A., Knobler H.Y., Lubin G., Harvey P.D., Rabinowitz J., Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J. Clin. Exp. Neuropsychol. 2006;28:193–207. doi: 10.1080/13803390500360372. - DOI - PubMed
    1. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr. Bull. 2007;33:912–920. doi: 10.1093/schbul/sbm046. - DOI - PMC - PubMed

Substances